These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31234906)

  • 1. Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report.
    Iacono A; Sprocati M; Giuliani AL; Di Virgilio F; Borgna-Pignatti C; Maggiore G
    Ital J Pediatr; 2019 Jun; 45(1):73. PubMed ID: 31234906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA).
    Hedrich CM; Bruck N; Fiebig B; Gahr M
    Rheumatol Int; 2012 Nov; 32(11):3525-30. PubMed ID: 22083619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis.
    Gattorno M; Piccini A; Lasigliè D; Tassi S; Brisca G; Carta S; Delfino L; Ferlito F; Pelagatti MA; Caroli F; Buoncompagni A; Viola S; Loy A; Sironi M; Vecchi A; Ravelli A; Martini A; Rubartelli A
    Arthritis Rheum; 2008 May; 58(5):1505-15. PubMed ID: 18438814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registry.
    Lainka E; Baehr M; Raszka B; Haas JP; Hügle B; Fischer N; Foell D; Hinze C; Weissbarth-Riedel E; Kallinich T; Horneff G; Windschall D; Lilienthal E; Niehues T; Neudorf U; Berendes R; Küster RM; Oommen PT; Rietschel C; Lutz T; Weller-Heinemann F; Tenbrock K; Heubner GL; Klotsche J; Wittkowski H
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):38. PubMed ID: 33752669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review.
    Aguiar CL; Pan N; Adams A; Barinstein L; Lehman TJ
    Clin Rheumatol; 2015 Oct; 34(10):1821-4. PubMed ID: 25697878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anakinra for myocarditis in juvenile idiopathic arthritis.
    Movva R; Brown SB; Morris DL; Figueredo VM
    Tex Heart Inst J; 2013; 40(5):623-5. PubMed ID: 24391342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
    Wagner-Weiner L
    Pediatr Ann; 2015 Jun; 44(6):e142-7. PubMed ID: 26114369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis.
    Kessel C; Lippitz K; Weinhage T; Hinze C; Wittkowski H; Holzinger D; Fall N; Grom AA; Gruen N; Foell D
    Arthritis Rheumatol; 2017 Jul; 69(7):1480-1494. PubMed ID: 28296284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis.
    Ter Haar NM; Tak T; Mokry M; Scholman RC; Meerding JM; de Jager W; Verwoerd A; Foell D; Vogl T; Roth J; Leliefeld PHC; van Loosdregt J; Koenderman L; Vastert SJ; de Roock S
    Arthritis Rheumatol; 2018 Jun; 70(6):943-956. PubMed ID: 29426067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis.
    Saccomanno B; Tibaldi J; Minoia F; Bagnasco F; Pistorio A; Guariento A; Caorsi R; Consolaro A; Gattorno M; Ravelli A
    J Rheumatol; 2019 Apr; 46(4):416-421. PubMed ID: 30647180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA).
    Ohlsson V; Baildam E; Foster H; Jandial S; Pain C; Strike H; Ramanan AV
    Rheumatology (Oxford); 2008 Apr; 47(4):555-6. PubMed ID: 18321945
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac tamponade in a child with systemic-onset juvenile idiopathic arthritis: dramatic improvement after interleukin-1 blockade by anakinra.
    Merlin E; Berthomieu L; Dauphin C; Stéphan JL
    Pediatr Cardiol; 2011 Aug; 32(6):862-3. PubMed ID: 21544583
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anakinra treatment in refractory systemic onset juvenile arthritis].
    Garrido Colino C; Saavedra Lozano J
    An Pediatr (Barc); 2008 Mar; 68(3):305-6. PubMed ID: 18358148
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.
    Vastert SJ; de Jager W; Noordman BJ; Holzinger D; Kuis W; Prakken BJ; Wulffraat NM
    Arthritis Rheumatol; 2014 Apr; 66(4):1034-43. PubMed ID: 24757154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.
    Horneff G; Schulz AC; Klotsche J; Hospach A; Minden K; Foeldvari I; Trauzeddel R; Ganser G; Weller-Heinemann F; Haas JP
    Arthritis Res Ther; 2017 Nov; 19(1):256. PubMed ID: 29166924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management.
    Kumar S
    Indian J Pediatr; 2016 Apr; 83(4):322-7. PubMed ID: 26916892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?
    Nigrovic PA
    Arthritis Rheumatol; 2014 Jun; 66(6):1405-13. PubMed ID: 24623686
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis.
    Baris HE; Anderson E; Sozeri B; Dedeoglu F
    Clin Rheumatol; 2018 Dec; 37(12):3263-3273. PubMed ID: 30238379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.